2,329
Views
60
CrossRef citations to date
0
Altmetric
Original Article

Liver transplantation in the Nordic countries – An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982–2013

, , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 797-808 | Received 12 Mar 2015, Accepted 29 Mar 2015, Published online: 09 May 2015

References

  • National Institutes of Health Consensus Development Conference: liver transplantation. R I Med J 1984;67:73–6.
  • KBKlein, TDStafinski, DMenon. Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature. PLoS ONE 2013;8:e80661.
  • MBlachier, HLeleu, MPeck-Radosavljevic, DCValla, FRoudot-Thoraval. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013;58:593–608.
  • RAdam, VKaram, VDelvart, JO’Grady, DMirza, JKlempnauer, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012;57:675–88.
  • KMBoberg, EAadland, JJahnsen, NRaknerud, MStiris, HBell. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998;33:99–103.
  • AEscorsell, APares, JRodes, JASolis-Herruzo, MMiras, Ede la Morena. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol 1994;21:787–91.
  • SBellentani, CTiribelli, GSaccoccio, MSodde, NFratti, MCDe, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994;20:1442–9.
  • CLvan der Poel, FEbeling. Hepatitis C virus: epidemiology, transmission and prevention. Curr Stud Hematol Blood Transfus 1998;62:208–36.
  • BChristenson, MBottiger, LGrillner. The prevalence of hepatitis B in Sweden; a statistical serosurvey of 3381 Swedish inhabitants. Epidemiol Infect 1997;119:221–5.
  • HBismuth, DCastaing, BGEriczon, JBOtte, KRolles, BRinge, et al. Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet 1987;2:674–6.
  • MSRoberts, DCAngus, CLBryce, ZValenta, LWeissfeld. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004;10:886–97.
  • MFLevy, PSSomasundar, LWJennings, GJJung, EPMolmenti, CGFasola, et al. The elderly liver transplant recipient: a call for caution. Ann Surg 2001;233:107–13.
  • DPagano, GGrosso, GVizzini, MSpada, DCintorino, MMalaguarnera, et al. Recipient-donor age matching in liver transplantation: a single-center experience. Transplant Proc 2013;45:2700–6.
  • ECholongitas, LMarelli, VShusang, MSenzolo, KRolles, DPatch, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006;12:1049–61.
  • LMMcElroy, ADaud, AEDavis, BLapin, TBaker, MMAbecassis, et al. A meta-analysis of complications following deceased donor liver transplant. Am J Surg 2014;208:605–18.
  • KMBoberg. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 2002;6:635–47.
  • KBjoro, BBrandsaeter, AFoss, ESchrumpf. Liver transplantation in primary sclerosing cholangitis. Semin Liver Dis 2006;26:69–79.
  • KBjoro, SFriman, KHockerstedt, PKirkegaard, SKeiding, ESchrumpf, et al. Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol 1999;34:714–22.
  • EMelum, ESchrumpf, KBjoro. Liver TX for hepatitis C cirrhosis in a low prevalence population: risk factors and status at evaluation. Scand J Gastroenterol 2006;41:592–6.
  • RWiesner, EEdwards, RFreeman, AHarper, RKim, PKamath, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91–6.
  • ECholongitas, AKBurroughs. The evolution in the prioritization for liver transplantation. Ann Gastroenterol 2012;25:6–13.
  • PSKamath, RHWiesner, MMalinchoc, WKremers, TMTherneau, CLKosberg, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–70.
  • PSKamath, WRKim. The model for end-stage liver disease (MELD). Hepatology 2007;45:797–808.
  • NGrunnet, MBodvarsson, AJakobsen, LKyllonen, MOlausson, PPfeffer, et al. Scandiatransplant report. 2009;Transplant Proc 2010;42:4429–31.
  • SAune, GSchistad, ASkulberg. Human liver transplantation without azathioprine. Surg Gynecol Obstet 1972;135:727–8.
  • SAune. Orthotopic liver transplantation. Ann Chir Gynaecol Fenn 1973;62:175–7.
  • GMAbouna. Organ shortage crisis: problems and possible solutions. Transplant Proc 2008;40:34–8.
  • APMartin, MBartels, JHauss, JFangmann. Overview of the MELD score and the UNOS adult liver allocation system. Transplant Proc 2007;39:3169–74.
  • MStepanova, HWai, SSaab, AMishra, CVenkatesan, ZYounossi. The outcomes of adult liver transplants in the united states from 1987 to 2013. Liver Int 2015. [Epub ahead of print].
  • AJain, JReyes, RKashyap, SFDodson, AJDemetris, KRuppert, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000;232:490–500.
  • FAberg, MGissler, THKarlsen, BGEriczon, AFoss, ARasmussen, et al. Differences in long-term mortality among liver transplant recipients and the general population: A population-based Nordic study. Hepatology 2015;61:668–77.
  • CPetersen, DHarder, ZAbola, DAlberti, TBecker, CChardot, et al. European biliary atresia registries: summary of a symposium. Eur J Pediatr Surg 2008;18:111–16.
  • TKumagi, JPDrenth, OGuttman, VNg, LLilly, GTherapondos, et al. Biliary atresia and survival into adulthood without transplantation: a collaborative multicentre clinic review. Liver Int 2012;32:510–18.
  • KMBoberg, GELind. Primary sclerosing cholangitis and malignancy. Best Pract Res Clin Gastroenterol 2011;25:753–64.
  • EBjornsson, JOlsson, ARydell, KFredriksson, CEriksson, CSjoberg, et al. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism. Scand J Gastroenterol 2005;40:206–16.
  • MCornberg, HARazavi, AAlberti, EBernasconi, MButi, CCooper, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011;31:30–60.
  • GRimseliene, ONilsen, HKlovstad, HBlystad, PAavitsland. Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009. BMC Infect Dis 2011;11:153.
  • ODalgard, SJeansson, KSkaug, NRaknerud, HBell. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol 2003; 38:864–70.
  • GHoffmann, GBerglund, SElmstahl, SEriksson, HVerbaan, AWidell, et al. Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population. Scand J Gastroenterol 2000;35:861–5.
  • SScaglione, SKliethermes, GCao, DShoham, RDurazo, ALuke, et al. The Epidemiology of Cirrhosis in the United States: A Population-based Study. J Clin Gastroenterol 2014; Epub ahead of print.
  • VMazzaferro, SBhoori, CSposito, MBongini, MLanger, RMiceli, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl 2011;17:S44–57.
  • TUnek, SKarademir, NCArslan, TEgeli, GAtasoy, OSagol, et al. Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma. World J Gastroenterol 2011;17:4206–12.
  • PDLine, THKarlsen, KMBoberg, ESchrumpf, BFosby, ØBentdal, et al. Outcome after liver transplantation for hepatocellular carcinoma (HCC) on extended criteria. Abstract presented at The Scandinavian Transplantation Society XXVI Congress, Reykjavik, Iceland, May 9-12. 2012.
  • RKoschny, JSchmidt, TMGanten. Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis. Clin Transplant 2009;23:49–60.
  • TPiardi, MAudet, MOdeh, FPanaro, MCag, JEl-ahmar, et al. Liver transplantation exceeding UCSF criteria: case report of a late recurrence treated by surgery and review of the literature. Eur Surg Res 2010;44:52–5.
  • SFriman, AFoss, HIsoniemi, MOlausson, KHockerstedt, SYamamoto, et al. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results. Scand J Gastroenterol 2011;46:370–5.
  • MHagness, AFoss, PDLine, TScholz, PFJorgensen, BFosby, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg 2013;257:800–6.